Ocular Hypertension and Primary Open-Angle Glaucoma: An Update on Treatment Regimens Webinar
Overview
There is every indication that innovations in pharmacotherapy will continue to play a crucial role in the clinical management of patients with glaucoma. During this webcast event, experts will discuss the current state of medical management of glaucoma and the various pipeline entities that proffer to increase the odds of helping patients with glaucoma preserve their vision. We will discuss new classes of medications, intriguing research on drug delivery devices, and exciting theories about how we approach treatment that may unveil potential curative strategiesThis continuing medical education activity is supported through an educational grant from Bausch & Lomb Incorporated. Learning Objectives
Learning Objectives Upon completion of this activity, the participant should be able to: - Discuss the limitations of current treatment regimens from both mechanism of action and patient compliance.
- Explain how novel therapeutics differ in their methods of action from commercially available topical medications
- Evaluate the safety and efficacy of different treatment modalities for ocular hypertension and primary open-angle glaucoma
- Assess the latest clinical trial data pertaining to new therapies
- Discuss future developments and direction of therapeutics for managing glaucoma
Accreditation
Accreditation Statement Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians Credit Designation Statement Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Jason Bacharach, MD North Bay Eye Associates Sonoma, California
Murray Fingeret, OD New York Harbor Healthcare System Brooklyn, New York
Jason Bacharach, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; Allergan plc and Glaukos Corporation. Grant/Research Support: Aerie Pharmaceuticals, Inc.; Alcon; Allergan plc; Bausch & Lomb Incorporated; Glaukos Corporation; and Ocular Therapeutix, Inc.Murray Fingeret, OD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Aerie Pharmaceuticals; Alcon, Allergan plc; Carl Zeiss Meditec; and Inotek Pharmaceuticals. Grant/Research Support: Carl Zeiss Meditec; Heidelberg Engineering; and Topcon Medical Systems.EDITORIAL SUPPORT DISCLOSURES
Cheryl Cavanaugh, MS, director of operations, Evolve Medical Education LLC, and Michelle Dalton, medical writer, have no real or apparent conflicts of interest to report.
Rishi P. Singh, MD, peer reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/ Speaker’s Bureau: Alcon; Allergan; Carl Zeiss Meditec; Genentech; Optos; Regeneron Pharmaceuticals; and Shire Plc. Grant/Research Support: Alcon; Apellis Pharmaceuticals; Genentech; and Regeneron Pharmaceuticals.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC and Bausch & Lomb Incorporated System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!